Literature DB >> 22068052

An indirect role for ASPP1 in limiting p53-dependent p21 expression and cellular senescence.

Arnaud M Vigneron1, Karen H Vousden.   

Abstract

In addition to acting as a transcriptional cofactor for p53, ASPP1 has been shown to function in the cytoplasm to regulate the nuclear localization and activity of YAP/TAZ. We show here that the ability of ASPP1 to activate YAP results in the decreased expression of LATS2, which lowers the ability of p53 to induce p21, cell-cycle arrest and senescence. ASPP1 expression peaks in S-phase, and down-regulation of ASPP1 leads to a reduction in DNA synthesis and enhanced senescence in response to drugs that impede DNA replication. These activities of cytoplasmic ASPP1 in opposing p53-mediated p21 expression are in contrast to the role of nuclear ASPP1 in cooperating with p53 to induce the expression of apoptotic target genes, and may help to dampen p53 activity in normal cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22068052      PMCID: PMC3261561          DOI: 10.1038/emboj.2011.402

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  41 in total

1.  ASPP proteins specifically stimulate the apoptotic function of p53.

Authors:  Y Samuels-Lev; D J O'Connor; D Bergamaschi; G Trigiante; J K Hsieh; S Zhong; I Campargue; L Naumovski; T Crook; X Lu
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

2.  PP1 cooperates with ASPP2 to dephosphorylate and activate TAZ.

Authors:  Chen-Ying Liu; Xianbo Lv; Tingting Li; Yanping Xu; Xin Zhou; Shimin Zhao; Yue Xiong; Qun-Ying Lei; Kun-Liang Guan
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

3.  A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint.

Authors:  Gabor Rohaly; Jan Chemnitz; Silke Dehde; Alejandro Mena Nunez; Jochen Heukeshoven; Wolfgang Deppert; Irena Dornreiter
Journal:  Cell       Date:  2005-07-15       Impact factor: 41.582

4.  TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway.

Authors:  Qun-Ying Lei; Heng Zhang; Bin Zhao; Zheng-Yu Zha; Feng Bai; Xin-Hai Pei; Shimin Zhao; Yue Xiong; Kun-Liang Guan
Journal:  Mol Cell Biol       Date:  2008-01-28       Impact factor: 4.272

5.  The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1.

Authors:  Yael Aylon; Yaara Ofir-Rosenfeld; Norikazu Yabuta; Eleonora Lapi; Hiroshi Nojima; Xin Lu; Moshe Oren
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

6.  Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs.

Authors:  B D Chang; Y Xuan; E V Broude; H Zhu; B Schott; J Fang; I B Roninson
Journal:  Oncogene       Date:  1999-08-26       Impact factor: 9.867

7.  The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage.

Authors:  Sabrina Strano; Olimpia Monti; Natalia Pediconi; Alessia Baccarini; Giulia Fontemaggi; Eleonora Lapi; Fiamma Mantovani; Alexander Damalas; Gennaro Citro; Ada Sacchi; Giannino Del Sal; Massimo Levrero; Giovanni Blandino
Journal:  Mol Cell       Date:  2005-05-13       Impact factor: 17.970

8.  Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells.

Authors:  D J Kurz; S Decary; Y Hong; J D Erusalimsky
Journal:  J Cell Sci       Date:  2000-10       Impact factor: 5.285

9.  Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation.

Authors:  Y Aylon; N Yabuta; H Besserglick; Y Buganim; V Rotter; H Nojima; M Oren
Journal:  Oncogene       Date:  2009-10-26       Impact factor: 9.867

10.  RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein.

Authors:  David Matallanas; David Romano; Karen Yee; Katrin Meissl; Lucia Kucerova; Daniela Piazzolla; Manuela Baccarini; J Keith Vass; Walter Kolch; Eric O'neill
Journal:  Mol Cell       Date:  2007-09-21       Impact factor: 17.970

View more
  8 in total

1.  ATM kinase enables the functional axis of YAP, PML and p53 to ameliorate loss of Werner protein-mediated oncogenic senescence.

Authors:  F Fausti; S Di Agostino; M Cioce; P Bielli; C Sette; P P Pandolfi; M Oren; M Sudol; S Strano; G Blandino
Journal:  Cell Death Differ       Date:  2013-08-09       Impact factor: 15.828

2.  Exploiting Expression of Hippo Effector, Yap, for Expansion of Functional Islet Mass.

Authors:  Nicholas M George; Brian P Boerner; Shakeel U R Mir; Zachary Guinn; Nora E Sarvetnick
Journal:  Mol Endocrinol       Date:  2015-09-17

Review 3.  The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.

Authors:  Noa Furth; Yael Aylon
Journal:  Cell Death Differ       Date:  2017-06-23       Impact factor: 15.828

Review 4.  p53 shades of Hippo.

Authors:  Noa Furth; Yael Aylon; Moshe Oren
Journal:  Cell Death Differ       Date:  2017-10-06       Impact factor: 15.828

Review 5.  Asparaginase treatment side-effects may be due to genes with homopolymeric Asn codons (Review-Hypothesis).

Authors:  Julian Banerji
Journal:  Int J Mol Med       Date:  2015-07-15       Impact factor: 4.101

Review 6.  A prospect of cell immortalization combined with matrix microenvironmental optimization strategy for tissue engineering and regeneration.

Authors:  Yiming Wang; Song Chen; Zuoqin Yan; Ming Pei
Journal:  Cell Biosci       Date:  2019-01-05       Impact factor: 7.133

7.  HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis.

Authors:  Yifan Chen; Kewu Pan; Pingzhang Wang; Zhengyi Cao; Weibin Wang; Shuya Wang; Ningguang Hu; Junhui Xue; Hui Li; Wei Jiang; Gang Li; Xiaowei Zhang
Journal:  J Biol Chem       Date:  2016-04-21       Impact factor: 5.157

8.  The feedback loop of ANKHD1/lncRNA MALAT1/YAP1 strengthens the radioresistance of CRC by activating YAP1/AKT signaling.

Authors:  Ping-An Yao; Yong Wu; Kui Zhao; Yecheng Li; Jianping Cao; Chungen Xing
Journal:  Cell Death Dis       Date:  2022-02-02       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.